|
|
Conference Program
Thursday November 13 |
8.45 |
Welcome and Introduction, Paul Carton and Floyd Bloom, The Scripps Research Institute, La Jolla, USA |
Session I Post-traumatic stress disorder - diagnosis, treatment and vulnerability factors
Chair: Dennis Charney, The Mount Sinai Medical Center, New York, USA |
9.00 |
PTSD and traumatic stress: From gene to community and from bed to bench...to bed
Robert J. Ursano, Uniformed Services University, Bethesda, USA |
9.45 |
Pharmacotherapy of PTSD: Past, present and future
Murray Stein, University of California, San Diego, USA |
10.30 |
Coffee Break |
11.00 |
The human neurobiology of resilience and PTSD
John Krystal, Yale University, New Haven, USA |
Session II: Stress and coping - human studies and animal models
Chair: Trevor Robbins, University of Cambridge, UK |
11.45 |
Stress and the brain reward system: how psychosocial stress might promote drug addiction and obesity
Alain Dagher, McGill, Montreal, Canada |
12.30 |
Interindividual differences in stress responsivity in human populations: Evidence from endocrinological and neuroimaging studies
Jens Pruessner, McGill, Montreal, Canada |
1.15 |
Lunch |
2.15 |
Brain stress systems and addiction
George.F. Koob, The Scripps Research Institute, La Jolla, USA |
Session III: Neuroendocrine adaptations to stress and their consequences
Chair: Huda Akil, University of Michigan, Ann Arbour, USA |
3.00 |
Cellular substrates underlying affective resilience: Implications for the long-term treatment of mood and anxiety disorders
Husseini Manji, NIMH, Bethesda, USA |
3.45 |
Coffee Break |
4.15 |
Amygdala Glucocorticoid receptor action in the behavioral and endocrine responses to stress
Louis Muglia, Washington University, St Louis, USA |
5.00 |
Corticosteroid influences on limbic neurons, from minutes to months
Marian Joëls, University of Amsterdam, The Netherlands |
5.45 |
Wrap up day 1 |
6.00– 7.30 |
Poster reception |
Friday November 14 |
Session IV: Neuroendocrine adaptations to stress - Part B
Chair: Bruce McEwen, Rockefeller University, New York, USA |
9.00 |
Behavioral consequences of neuronal atrophy and loss caused by stress: Reversal by antidepressant treatment
Ronald Duman, Yale University, New Haven, USA |
9.45 |
Hippocampal neurogenesis: Regulation by stress and antidepressant
René Hen, Columbia University, New York, USA |
10.30 |
Coffee Break |
11.00 |
Why is the pattern of glucocorticoid secretion important?
Stafford Lightman, University of Bristol, UK |
Session V: Prefrontal cortex and responses to stress
Chair: Alan Sved, University of Pittsburgh, USA |
11.45 |
Neural control of the heart: Implications for health and disease
Julian Thayer, Ohio State University, Columbus, USA |
12.30 |
Role of the medial prefrontal cortex in coping and resilience
Steve Maier, University of Colorado, Boulder, USA |
1.15 |
Lunch |
2.15 |
Effects of stress on medial prefrontal cortex: Potential for recovery
John Morrison, Mount Sinai School of Medicine, New York, USA |
Session VI: Stress and memory
Chair: James McGaugh, University of California, Irvine, USA |
3.00 |
Adrenal stress hormones, amygdala activation, and memory for emotionally arousing experiences
Benno Roozendaal, University of California, Irvine, USA |
3.45 |
Coffee Break |
4.15 |
Stress and memory in humans
Oliver Wolf, Ruhr University Bochum, Germany |
5.00 |
Stress-related susceptibility pathways
Ronald de Kloet, Leiden University, The Netherlands |
5.45 |
Closing |
|
Supported by
(2008 Media Partners)
|
